ISRG vs. VEEV: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ISRG and VEEV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | ISRG | VEEV |
|---|---|---|
| Company Name | Intuitive Surgical, Inc. | Veeva Systems Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Health Care Technology |
| Market Capitalization | 196.99 billion USD | 47.17 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | June 16, 2000 | October 16, 2013 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ISRG and VEEV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ISRG | VEEV |
|---|---|---|
| 5-Day Price Return | -4.63% | -0.81% |
| 13-Week Price Return | 14.42% | 4.54% |
| 26-Week Price Return | -2.56% | 21.63% |
| 52-Week Price Return | 2.39% | 25.80% |
| Month-to-Date Return | 2.85% | 0.74% |
| Year-to-Date Return | 5.28% | 39.53% |
| 10-Day Avg. Volume | 2.18M | 0.83M |
| 3-Month Avg. Volume | 2.35M | 1.20M |
| 3-Month Volatility | 39.64% | 28.15% |
| Beta | 1.67 | 1.04 |
Profitability
Return on Equity (TTM)
ISRG
16.06%
Health Care Equipment & Supplies Industry
- Max
- 29.82%
- Q3
- 15.54%
- Median
- 9.69%
- Q1
- 5.19%
- Min
- -7.98%
In the upper quartile for the Health Care Equipment & Supplies industry, ISRG’s Return on Equity of 16.06% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
VEEV
13.40%
Health Care Technology Industry
- Max
- 48.09%
- Q3
- 42.04%
- Median
- 18.65%
- Q1
- 11.64%
- Min
- 11.05%
VEEV’s Return on Equity of 13.40% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ISRG
28.58%
Health Care Equipment & Supplies Industry
- Max
- 24.65%
- Q3
- 14.10%
- Median
- 10.09%
- Q1
- 5.84%
- Min
- -6.13%
ISRG’s Net Profit Margin of 28.58% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
VEEV
27.29%
Health Care Technology Industry
- Max
- 52.24%
- Q3
- 49.36%
- Median
- 34.00%
- Q1
- 16.86%
- Min
- 13.38%
VEEV’s Net Profit Margin of 27.29% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ISRG
29.30%
Health Care Equipment & Supplies Industry
- Max
- 31.34%
- Q3
- 18.36%
- Median
- 15.07%
- Q1
- 9.62%
- Min
- -0.13%
An Operating Profit Margin of 29.30% places ISRG in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
VEEV
26.93%
Health Care Technology Industry
- Max
- 74.05%
- Q3
- 65.47%
- Median
- 33.33%
- Q1
- 22.83%
- Min
- 21.46%
VEEV’s Operating Profit Margin of 26.93% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | ISRG | VEEV |
|---|---|---|
| Return on Equity (TTM) | 16.06% | 13.40% |
| Return on Assets (TTM) | 14.18% | 10.96% |
| Net Profit Margin (TTM) | 28.58% | 27.29% |
| Operating Profit Margin (TTM) | 29.30% | 26.93% |
| Gross Profit Margin (TTM) | 66.38% | 75.59% |
Financial Strength
Current Ratio (MRQ)
ISRG
4.97
Health Care Equipment & Supplies Industry
- Max
- 4.97
- Q3
- 2.92
- Median
- 2.12
- Q1
- 1.54
- Min
- 0.86
ISRG’s Current Ratio of 4.97 is in the upper quartile for the Health Care Equipment & Supplies industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
VEEV
5.57
Health Care Technology Industry
- Max
- 7.79
- Q3
- 6.49
- Median
- 6.03
- Q1
- 3.62
- Min
- 2.96
VEEV’s Current Ratio of 5.57 aligns with the median group of the Health Care Technology industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ISRG
0.00
Health Care Equipment & Supplies Industry
- Max
- 1.62
- Q3
- 0.74
- Median
- 0.47
- Q1
- 0.15
- Min
- 0.00
Falling into the lower quartile for the Health Care Equipment & Supplies industry, ISRG’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
VEEV
0.00
Health Care Technology Industry
- Max
- 0.14
- Q3
- 0.10
- Median
- 0.01
- Q1
- 0.00
- Min
- 0.00
Falling into the lower quartile for the Health Care Technology industry, VEEV’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
ISRG
--
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 24.86
- Median
- 9.84
- Q1
- 3.86
- Min
- -21.65
Interest Coverage Ratio data for ISRG is currently unavailable.
VEEV
169.00
Health Care Technology Industry
- Max
- 224.12
- Q3
- 224.12
- Median
- 219.00
- Q1
- 219.00
- Min
- 219.00
VEEV’s Interest Coverage Ratio of 169.00 is below the typical range for the Health Care Technology industry. This suggests a weaker ability to meet debt obligations compared to its peers and may indicate a higher level of financial risk.
Financial Strength at a Glance
| Symbol | ISRG | VEEV |
|---|---|---|
| Current Ratio (MRQ) | 4.97 | 5.57 |
| Quick Ratio (MRQ) | 4.20 | 5.48 |
| Debt-to-Equity Ratio (MRQ) | 0.00 | 0.00 |
| Interest Coverage Ratio (TTM) | -- | 169.00 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ISRG
0.00%
Health Care Equipment & Supplies Industry
- Max
- 4.36%
- Q3
- 1.87%
- Median
- 0.82%
- Q1
- 0.00%
- Min
- 0.00%
ISRG currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
VEEV
0.00%
Health Care Technology Industry
- Max
- 0.77%
- Q3
- 0.62%
- Median
- 0.19%
- Q1
- 0.05%
- Min
- 0.00%
VEEV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
ISRG
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 67.77%
- Median
- 28.21%
- Q1
- 0.00%
- Min
- 0.00%
ISRG has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
VEEV
0.00%
Health Care Technology Industry
- Max
- 101.92%
- Q3
- 87.10%
- Median
- 42.63%
- Q1
- 10.66%
- Min
- 0.00%
VEEV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | ISRG | VEEV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
ISRG
70.92
Health Care Equipment & Supplies Industry
- Max
- 67.59
- Q3
- 41.41
- Median
- 33.11
- Q1
- 22.82
- Min
- 8.68
At 70.92, ISRG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.
VEEV
58.28
Health Care Technology Industry
- Max
- 225.71
- Q3
- 183.85
- Median
- 51.77
- Q1
- 45.26
- Min
- 35.02
VEEV’s P/E Ratio of 58.28 is within the middle range for the Health Care Technology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ISRG
20.27
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.92
- Q1
- 1.97
- Min
- 0.61
With a P/S Ratio of 20.27, ISRG trades at a valuation that eclipses even the highest in the Health Care Equipment & Supplies industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
VEEV
15.90
Health Care Technology Industry
- Max
- 117.92
- Q3
- 92.41
- Median
- 15.08
- Q1
- 8.11
- Min
- 6.06
VEEV’s P/S Ratio of 15.90 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ISRG
9.41
Health Care Equipment & Supplies Industry
- Max
- 10.77
- Q3
- 6.04
- Median
- 3.32
- Q1
- 2.31
- Min
- 0.83
ISRG’s P/B Ratio of 9.41 is in the upper tier for the Health Care Equipment & Supplies industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
VEEV
7.00
Health Care Technology Industry
- Max
- 115.01
- Q3
- 89.39
- Median
- 9.75
- Q1
- 4.04
- Min
- 3.06
VEEV’s P/B Ratio of 7.00 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | ISRG | VEEV |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 70.92 | 58.28 |
| Price-to-Sales Ratio (TTM) | 20.27 | 15.90 |
| Price-to-Book Ratio (MRQ) | 9.41 | 7.00 |
| Price-to-Free Cash Flow Ratio (TTM) | 85.77 | 35.54 |